Skip to main content
FinSpry Logo
FinSpry
IGC logo
IGC
(NYSEAMERICAN)
IGC Pharma, Inc.
$0.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

IGC Pharma (IGC) Stock Price & Financial Analysis

IGC Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.26 - $0.27
52-Week High$0.50
52-Week Low$0.24
Open$0.27
Volume88.60K
Average Volume (3M)88.60K
Market Cap23.98M
Shares Outstanding90.46M
Price to Sales (P/S)22.20
Price to Book (P/B)3.03
EV/EBITDA-3.13
Revenue (TTM)1.11M
Net Income (TTM)-6.45M
Free Cash Flow (TTM)-6.26M
EPS (TTM)$-0.07
Profit Margin-582.82%
Operating Margin-731.83%
Return on Equity (ROE)-79.66%
Debt to Equity0.02
50-Day MA$0.27
200-Day MA$0.34
52-Week Change-4.97%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About IGC Pharma

What is the current stock price for IGC?

As of the latest trading session, IGC stock trades at $0.27. The 52-week range is $0.24–$0.50, with a day range of $0.26–$0.27.

What is the P/E ratio for IGC?

The P/E ratio (Price-to-Earnings) for IGC is shown in the Key Statistics section. This valuation metric helps compare IGC Pharma, Inc. to industry peers.

Does IGC pay dividends?

IGC Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IGC?

Based on 1 analyst, the consensus for IGC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IGC?

IGC Pharma's market capitalization is $24.0M, classifying it as a micro-cap company. IGC Pharma operates in the Healthcare sector within the Biotechnology industry.